HAVCR2 and acute myeloid leukemia: In AML patients, both CD4+ and CD8+ T cells showed a decrease in the percentage of LAG-3+ TIM-3+ PD-1− cells and an increased percentage of LAG-3− TIM-3− PD-1− cells (supplementary Figure S7b).